Indian Patients Suffer from India’s Weak Pharmaceutical Patents – Forbes


Forbes
Indian Patients Suffer from India’s Weak Pharmaceutical Patents
Forbes
India’s recently elected Prime Minister, Narendra Modi, will visit the U.S. later this month. One of the sticking points in the U.S.-India relationship is weakness in India’s laws governing intellectual property (IP). The Global Intellectual Property

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd